5395242026-05-29Disclosure45395242026-05-29Disclosure35395242026-05-29Disclosure25395242026-05-29Disclosure15395242026-05-295395242026-05-29Disclosure5xbrli:sharesxbrli:pureiso4217:INR

Prohibition of Insider Trading


DR. LAL PATHLABS LIMITED

General information about company

Scrip Code539524
NSE SymbolLALPATHLAB
MSEI SymbolNOTLISTED
Name of the SignatoryVINAY GUJRAL
Designation of SignatoryCompany Secretary and Compliance Officer
PlaceGURUGRAM
Date of Filing29-05-2026
ISIN CodeINE600L01024
Disclosure under RegulationRegulation 7 (2)
Revised FilingNo

PIT Disclosure

Sr. No.Type of instrumentDescription of type of instrument (applicable in case of other is selected)Category of personName of the personCIN / DINSecurities held prior to acquisition / disposalSecurities acquired / disposedSecurities held post acquisition / disposalDate of allotment advice / acquisition of shares / sale of shares specifyMode of acquisition / disposalDate of intimation to companyType of contractContract specificationBuySellExchange on which the trade was executedNotes
No. of security% of shareholdingNo. of securityValue of security (in Rs.)Transaction typeNo. of security% of shareholdingFrom dateTo dateNotional valueNo. of units (contracts × lot size)Notional valueNo. of units (contracts × lot size)
1EquityOtherDr. Lal PathLabs Employee Welfare Trust6471460.39%53501,704,185.00Sell6417960.38%27-05-202629-05-2026ESOP29-05-2026NATextual Information(1)
2EquityDesignated PersonSanjay Kulshreshtha46280.00%10001,621,800.00Sell36280.00%27-05-202627-05-2026Market Sale29-05-2026NSE
3EquityDesignated PersonAnupa Dixit33500.00%12506,250.00Buy46000.00%27-05-202627-05-2026ESOP29-05-2026NATextual Information(2)
4EquityDesignated PersonPunit Sharma5200.00%10001,141,200.00Buy15200.00%27-05-202627-05-2026ESOP29-05-2026NATextual Information(3)
5EquityDesignated PersonJai Prakash Meena6000.00%200010,000.00Buy26000.00%27-05-202627-05-2026ESOP29-05-2026NATextual Information(4)

Text Block

Textual Information(1)It may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of INR 1141.20/-, 5/-, 1087.47/- per share (as the case may be) under Company’s ESOP plan(s).
Textual Information(2)It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share under Company’s ESOP Plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(3)It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 1,141.20/- per share under Company’s ESOP Plan.
Textual Information(4)It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share under Company’s ESOP Plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).